| Fees for the | Fees for the | ||||
| Date of | year ended 31 | Expenses | year ended 31 | ||
| appointment | December 2025 1 | Reimbursed 2 | Total | December 2024 1 | |
| to the Board | (£) | (£) | (£) | (£) | |
Miriam Greenwood | 19 April 2021 | 110,708 | – | 110,708 | 106,954 |
Nicholas Bliss | 9 April 2021 | 72,851 | – | 72,851 | 67,902 |
David Fletcher | 29 April 2022 | 86,548 | – | 86,548 | 83,613 |
Janine Freeman | 2 November 2022 | 72,851 | – | 72,851 | 67,9 02 |
Total | 342,958 | – | 342,958 | 326,371 |
| % change 2024 to | % change 2023 to | % change 2022 to | % change | |
| 2025 | 2024 | 2023 | 2021 to 2022 1 | |
Miriam Greenwood | 3.51 | 15.19 | 61.24 2 | – |
Nicholas Bliss | 7.29 | 13.56 | 41.60 3 | – |
David Fletcher | 3.51 | 16.35 | 135.17 4 | – |
Janine Freeman | 7.29 | 20.16 | 750.83 5 | – |
31 December 2025 | 31 December 2024 | |||||
| Connected | Connected | |||||
| Director | person | Total | Director | person | Total | |
Miriam Greenwood | 19,181 | – | 19,181 | 19,181 | – | 19,181 |
David Fletcher | 43,844 | 12,832 | 56,676 | 38,598 | 12,832 | 51,430 |
Nicholas Bliss | 16,280 | – | 16,280 | 16,280 | – | 16,280 |
Janine Freeman | – | – | – | – | – | – |
For the year ended 31 December 2025 | For the year ended 31 December 2024 | ||||||
| Revenue | Capital | Total | Revenue | Capital | Total | ||
| Notes | £‘000 | £‘000 | £‘000 | £‘000 | £‘000 | £‘000 | |
Losses on investments at fair value through profit or loss | 5 | ( | ( | ( | ( | ||
Unrealised gains/(losses) on derivatives | 5 | ( | ( | ||||
Realised (losses)/gains on derivatives | ( | ( | |||||
Net foreign exchange gains/(losses) | ( | ( | |||||
Investment income | 6 | ||||||
Investment advisory fees | 7 | ( | ( | ( | ( | ||
Impairment loss | 5 | ( | ( | ( | ( | ||
Administrative expenses | 8 | ( | ( | ( | ( | ||
(Loss)/profit before taxation | ( | ( | ( | ( | ( | ||
Taxation | 9 | ||||||
(Loss)/profit after taxation | ( | ( | ( | ( | ( | ||
(Losses)/earnings per share | 10 | ( | ( | ( | ( | ( |
| As at | As at | ||
| 31 December | 31 December | ||
| 2025 | 2024 | ||
| £‘000 | £‘000 | ||
| Fixed assets | |||
Investments at fair value through profit or loss | 5 | ||
Investments at amortised cost | 5 | ||
Current assets | 12 | ||
Receivables | |||
Cash at bank and in hand | |||
Derivative financial instruments | |||
Creditors: amounts falling due within one year | 13 | ||
Payables | ( | ( | |
Derivative financial instruments | ( | ||
Net current assets | |||
Total assets less current liabilities | |||
Net assets | |||
| Capital and reserves | |||
Share capital | 14 | ||
Capital redemption reserve | 15 | ||
Special reserve | 15 | ||
Capital reserve | 15 | ( | ( |
Revenue reserve | 15 | ( | ( |
Total equity shareholders' funds | |||
Net asset value per share | 16 | ||
Number of shares in issue |
| For the year ended 31 December 2025 | |||||||
| Capital | |||||||
| Share | redemption | Special | Capital | Revenue | |||
| capital | reserve | reserve | reserve | reserve | Total | ||
| Notes | £‘000 | £‘000 | £‘000 | £‘000 | £‘000 | £‘000 | |
At 1 January 2025 | ( | ( | |||||
Dividends paid in the year | 11 | ( | ( | ||||
Profit/(loss) for the year | ( | ( | |||||
At 31 December 2025 | ( | ( | |||||
| For the year ended 31 December 2024 | Capital | ||||||
| Share | redemption | Special | Capital | Revenue | |||
| capital | reserve | reserve | reserve | reserve | Total | ||
| Notes | £‘000 | £‘000 | £‘000 | £‘000 | £‘000 | £‘000 | |
At 1 January 2024 | ( | ( | |||||
Repurchase and cancellation of the Company’s own shares following a Tender Offer | 14 | ( | ( | ( | |||
Expenses of Tender Offer | ( | ( | |||||
Dividend paid in the year | 11 | ( | ( | ||||
Loss for the year | ( | ( | ( | ||||
At 31 December 2024 | ( | ( |
| Year | Year | ||
| ended | ended | ||
| 31 December | 31 December | ||
| 2025 | 2024 | ||
| £‘000 | £‘000 | ||
| Operating activities | |||
Loss before taxation | ( | ( | |
| Adjustments for: | |||
Unrealised loss on investments | 5 | ||
Unrealised (gain)/loss on derivative instruments | 5 | ( | |
Realised loss on investments | 5 | ||
Impairment loss | 5 | ||
Net foreign exchange (gain)/loss | ( | ||
(Increase)/decrease in trade receivables | ( | ||
(Decrease)/increase in creditors: amounts falling due within one year | ( | ||
Interest receivable from amortised cost investments | 5 | ( | ( |
Net cash (outflow)/inflow from operating activities | ( | ||
| Investing activities | |||
Purchase of investments | 5 | ( | ( |
Repayment of investments | 5 | ||
Net cash inflow from investing activities | |||
| Financing activities | |||
Tender Offer payment | 14 | ( | |
Expenses of Tender Offer | ( | ||
Dividend paid | 11 | ( | ( |
Net cash outflow from financing activities | ( | ( | |
Decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at the start of the year | |||
Effect of foreign currency exchange translation | ( | ||
Cash and cash equivalents at the end of the year |
| 31 December 2025 | 31 December 2024 | |
| £’000 | £’000 | |
Level 1 | – | – |
Level 2 – Derivative financial instruments | 274 | (24) |
Level 3 – Investments at fair value through profit or loss | 1,867 | 10,022 |
Total | 2,141 | 9,998 |
| Year ended | Year ended | |
| 31 December 2025 | 31 December 2024 | |
| £’000 | £’000 | |
Opening balance | 10,022 | 10,492 |
Additions during the year | – | 3,683 |
Disposals during the year | (7,260) | (1,564) |
Realised losses | (157) | (17) |
Unrealised losses | (815) | (2,060) |
Net foreign exchange gains/(losses) | 77 | (512) |
Closing balance | 1,867 | 10,022 |
| Year ended | Year ended | |
| 31 December 2025 | 31 December 2024 | |
| £’000 | £’000 | |
Opening balance | 46,309 | 54,990 |
Additions during the year | 36 | 541 |
Receipts during the year | (22,558) | (8,330) |
Income accrued during the year | 2,948 | 4,008 |
Net foreign exchange gains/(losses) | 1,829 | (2,346) |
Impairment | (1,999) | (2,554) |
Closing balance | 26,565 | 46,309 |
| 31 December 2025 | 31 December 2024 | |
| £’000 | £’000 | |
Investment in the Italian SPV held at fair value through profit or loss | 9,738 | 29,351 |
Investment in AHL held at cost less impairment | 8,209 | 9,048 |
Total | 17,947 | 38,399 |
| 31 December 2025 | 31 December 2024 | |
| £’000 | £’000 | |
Level 1 | – | – |
Level 2 | – | – |
Level 3 – Investment in the Italian SPV | 9,738 | 29,351 |
Total | 9,738 | 29,351 |
| Year ended | Year ended | |
| 31 December 2025 | 31 December 2024 | |
| £’000 | £’000 | |
Opening balance | 29,351 | 35,683 |
Additions during the year | – | 294 |
Repayments during the year | (19,129) | (3,724) |
Net foreign exchange gains/(losses) | 1,051 | (1,603) |
Unrealised losses | (1,535) | (1,299) |
Closing balance | 9,738 | 29,351 |
| Year ended | Year ended | |
| 31 December 2025 | 31 December 2024 | |
| £’000 | £’000 | |
Opening gross carrying amount | 11,791 | 11,791 |
Additions during the year | – | – |
Closing gross carrying amount | 11,791 | 11,791 |
| Accumulated impairment: | ||
Opening accumulated impairment balance | (2,743) | (1,820) |
Impairment recognised in the year | (839) | (923) |
Closing net carrying amount | 8,209 | 9,048 |
31 December 2025 | 31 December 2024 | |||
| Carrying value | Fair value | Carrying value | Fair value | |
| £’000 | £’000 | £’000 | £’000 | |
Group investments held at amortised cost | 26,565 | 26,081 | 46,309 | 46,543 |
31 December 2025 | 31 December 2024 | |||||
| Gross carrying | Allowance | Net carrying | Gross carrying | Allowance | Net carrying | |
| amount | for ECL | amount | amount | for ECL | amount | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Stage 1 | 20,662 | (118) | 20,544 | 21,194 | (118) | 21,076 |
Stage 2 | – | – | – | 27,156 | (1,923) | 25,233 |
Stage 3 | 12,327 | (6,306) | 6,021 | 2,384 | (2,384) | – |
Investments at amortised cost | 32,989 | (6,424) | 26,565 | 50,734 | (4,425) | 46,309 |
| Stage 1 ECL | Stage 2 ECL | Stage 3 ECL | Total | |
| Year ended 31 December 2025 | £’000 | £’000 | £’000 | £’000 |
Opening Balance | 118 | 1,923 | 2,384 | 4,425 |
Transfer from Stage 2 to Stage 1 | 16 | (16) | – | – |
Transfer from Stage 2 to Stage 3 | – | (1,763) | 1,763 | – |
Release on full repayment | – | (144) | – | (144) |
Movement in impairment | (16) | – | 2,159 | 2,143 |
Closing balance | 118 | – | 6,306 | 6,424 |
| Stage 1 ECL | Stage 2 ECL | Stage 3 ECL | Total | |
| Year ended 31 December 2024 | £’000 | £’000 | £’000 | £’000 |
Opening Balance | 259 | 24 | 1,588 | 1,871 |
Transfer from Stage 1 to Stage 2 | (95) | 95 | – | – |
Transfer from Stage 2 to Stage 3 | – | (24) | 24 | – |
Movement in impairment | (46) | 1,828 | 772 | 2,554 |
Closing balance | 118 | 1,923 | 2,384 | 4,425 |
| Year ended | Year ended | |
| 31 December 2025 | 31 December 2024 | |
| Group | £’000 | £’000 |
Investment interest income | 3,341 | 4,679 |
Bank interest | 507 | 718 |
Total investment income | 3,848 | 5,397 |
| Year ended | Year ended | |
| 31 December 2025 | 31 December 2024 | |
| Company | £’000 | £’000 |
Investment interest income | 2,204 | 3,797 |
Bank interest | 288 | 406 |
Total investment income | 2,492 | 4,203 |
| Group and Company | Year ended 31 December 2025 | Year ended 31 December 2024 | ||||
| Revenue | Capital | Total | Revenue | Capital | Total | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Investment advisory fee 1 | 454 | – | 454 | 647 | – | 647 |
Year ended 31 December 2025 | Year ended 31 December 2024 | |||||
| Revenue | Capital | Total | Revenue | Capital | Total | |
| Group | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
| Audit services: | ||||||
fees payable for the statutory audit of the Company’s and consolidated financial | ||||||
statements 1 | 592 | – | 592 | 506 | – | 506 |
fees payable for the statutory audit of subsidiaries 2 | 29 | – | 29 | 27 | – | 27 |
Directors’ fees 3 | 343 | – | 343 | 326 | – | 326 |
Company secretary and administration fees | 285 | – | 285 | 297 | – | 297 |
AIFM fees | 109 | – | 109 | 112 | – | 112 |
Legal fees | 98 | – | 98 | 169 | – | 169 |
Marketing fees | 75 | – | 75 | 93 | – | 93 |
Investment expenses | 73 | – | 73 | 169 | – | 169 |
Broker’s fees | 60 | – | 60 | 320 | – | 320 |
Other administrative expenses | 294 | – | 294 | 355 | – | 355 |
Total administrative expenses | 1,958 | – | 1,958 | 2,374 | – | 2,374 |
Year ended 31 December 2025 | Year ended 31 December 2024 | |||||
| Revenue | Capital | Total | Revenue | Capital | Total | |
| Company | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
| Audit services: | ||||||
fees payable for the statutory audit of the Company’s and consolidated financial | ||||||
statements 1 | 592 | – | 592 | 506 | – | 506 |
fees payable for the statutory audit of subsidiaries 2 | 29 | – | 29 | 27 | – | 27 |
Directors’ fees 3 | 240 | – | 240 | 228 | – | 228 |
Company secretary and administration fees | 206 | – | 206 | 219 | – | 219 |
AIFM fees | 109 | – | 109 | 112 | – | 112 |
Legal fees | 98 | – | 98 | 169 | – | 169 |
Marketing fees | 75 | – | 75 | 93 | – | 93 |
Broker’s fees | 60 | – | 60 | 320 | – | 320 |
Other administrative expenses | 220 | – | 220 | 265 | – | 265 |
Total administrative expenses | 1,629 | – | 1,629 | 1,939 | – | 1,939 |
Year ended 31 December 2025 | Year ended 31 December 2024 | |||||
| Revenue | Capital | Total | Revenue | Capital | Total | |
| Group | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
| Corporation tax | – | – | – | – | – | – |
| Taxation | – | – | – | – | – | – |
Year ended 31 December 2025 | Year ended 31 December 2024 | |||||
| Revenue | Capital | Total | Revenue | Capital | Total | |
| Company | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
| Corporation tax | – | – | – | – | – | – |
| Taxation | – | – | – | – | – | – |
Year ended 31 December 2025 | Year ended 31 December 2024 | |||||
| Revenue | Capital | Total | Revenue | Capital | Total | |
| Group | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
(Loss)/profit before taxation | (563) | 27 | (536) | (178) | (1,849) | (2,027) |
Corporation tax at 25% (2024: 25%) | (141) | 7 | (134) | (45) | (462) | (507) |
| Effects of: | ||||||
Excess management expenses | – | – | – | (30) | – | (30) |
| Deemed interest payment under income | ||||||
streaming rules | (383) | – | (383) | (52) | – | (52) |
Non deductible expenses | 524 | – | 524 | 162 | – | 162 |
| Movement on investments not allowable/ | ||||||
taxable | – | (7) | (7) | (35) | 462 | 427 |
Tax charge for the year | – | – | – | – | – | – |
Year ended 31 December 2025 | Year ended 31 December 2024 | |||||
| Revenue | Capital | Total | Revenue | Capital | Total | |
| Company | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
(Loss)/profit before taxation | (430) | (354) | (784) | 694 | (3,027) | (2,333) |
Corporation tax at 25% (2024: 25%) | (108) | (89) | (197) | 174 | (757) | (583) |
| Effects of: | ||||||
Movement in deferred tax not recognised | – | – | – | – | – | – |
| Excess management expenses brought | ||||||
forward | – | – | – | (30) | – | (30) |
Group relief | (126) | – | (126) | (460) | – | (460) |
| Deemed interest payment under income | ||||||
streaming rules | – | – | – | (77) | – | (77) |
Non deductible expenses | 234 | – | 234 | 393 | – | 393 |
| Movement on investments not allowable/ | ||||||
taxable | – | 89 | 89 | – | 757 | 757 |
Tax charge for the year | – | – | – | – | – | – |
| Year ended | Year ended | |
| 31 December | 31 December | |
| Group | 2025 | 2024 |
Revenue loss after taxation (£’000) | (563) | (178) |
Capital profit/(loss) after taxation (£’000) | 27 | (1,849) |
Total loss after taxation (£’000) | (536) | (2,027) |
Weighted average number of shares in issue during the year | 81,438,268 | 88,335,524 |
Revenue losses per share | (0.69)p | (0.20)p |
Capital earnings/(losses) per share | 0.03p | (2.09)p |
Total losses per share | (0.66)p | (2.29)p |
| Year ended | Year ended | |
| 31 December | 31 December | |
| Company | 2025 | 2024 |
Revenue (loss)/profit after taxation (£’000) | (430) | 694 |
Capital loss after taxation (£’000) | (354) | (3,027) |
Total loss after taxation (£’000) | (784) | (2,333) |
Weighted average number of shares in issue during the year | 81,438,268 | 88,335,524 |
Revenue (losses)/earning per share | (0.53)p | 0.79p |
Capital losses per share | (0.43)p | (3.43)p |
Total losses per share | (0.96)p | (2.64)p |
| Year ended | Year ended | |
| 31 December | 31 December | |
| 2025 | 2024 | |
| £’000 | £’000 | |
Interim paid on 1 November 2024 of 6.139p per share paid out of capital | – | 4,999 |
Interim paid on 30 May 2025 of 36.837p per share paid out of capital | 29,999 | – |
Interim paid on 24 October 2025 of 4.000p per share paid out of capital | 3,258 | – |
33,257 | 4,999 |
31 December 2025 | 31 December 2024 | |||
| Group | Company | Group | Company | |
| Receivables | £’000 | £’000 | £’000 | £’000 |
Trade and other receivables | 111 | 79 | 80 | 56 |
Shareholder Loan receivable | – | 27,514 | – | 27,292 |
Total | 111 | 27,593 | 80 | 27,348 |
31 December 2025 | 31 December 2024 | |||
| Group | Company | Group | Company | |
| Derivative financial instruments | £’000 | £’000 | £’000 | £’000 |
Forward currency contracts | 274 | – | – | – |
31 December 2025 | 31 December 2024 | |||
| Group | Company | Group | Company | |
| Payables | £’000 | £’000 | £’000 | £’000 |
Intercompany balance with Attika Holdings Limited 1 | – | 10,859 | – | 2,443 |
Accrued expenses | 749 | 625 | 1,094 | 968 |
Unsettled trades | – | – | 43 | – |
Total | 749 | 11,484 | 1,137 | 3,411 |
31 December 2025 | 31 December 2024 | |||
| Group | Company | Group | Company | |
| Derivative financial instruments | £’000 | £’000 | £’000 | £’000 |
Forward currency contracts | – | – | 24 | – |
| Year ended | Year ended | |
| 31 December | 31 December | |
| 2025 | 2024 | |
| Ordinary shares of 1p each, allotted, called-up and fully paid | £’000 | £’000 |
Opening balance of 81,438,268 (2024: 100,000,000) shares of 1p each | 814 | 1,000 |
Repurchase and cancellation of nil (2024: 18,561,732) shares following a Tender Offer | – | (186) |
Closing balance of 81,438,268 (2024: 81,438,268) shares | 814 | 814 |
| Capital | ||||
| redemption | Special | Capital | Revenue | |
| reserve | reserve | reserve | reserve | |
| Group | £’000 | £’000 | £’000 | £’000 |
At 1 January 2025 | 186 | 70,913 | (2,027) | (219) |
Dividends paid | – | (33,257) | – | – |
Profit/(loss) after taxation | – | – | 27 | (563) |
At 31 December 2025 | 186 | 37,656 | (2,000) | (782) |
| Capital | ||||
| redemption | Special | Capital | Revenue | |
reserve 1 | reserve 2 | reserve 3 | reserve 4 | |
| Company | £’000 | £’000 | £’000 | £’000 |
At 1 January 2025 | 186 | 70,913 | (104) | (1,853) |
Dividends paid | – | (33,257) | – | – |
(Loss)/profit after taxation | – | – | (354) | (430) |
At 31 December 2025 | 186 | 37,656 | (458) | (2,283) |
| 31 December | 31 December | |
| 2025 | 2024 | |
Consolidated NAV (£'000) | 35,874 | 69,667 |
Closing balance of shares in issue | 81,438,268 | 81,438,268 |
NAV per share | 44.05p | 85.55p |
31 December 2025 | 31 December 2024 | |||||
| GBP | Eur | Total | GBP | Eur | Total | |
| Assets | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Cash and cash equivalents | 7,346 | 460 | 7,806 | 7, 358 | 7,0 59 | 14,417 |
Trade and other receivables | 75 | 36 | 111 | 56 | 24 | 80 |
Derivative financial instruments | 274 | – | 274 | – | – | – |
Investments | 2,350 | 26,082 | 28,432 | 3,021 | 53,310 | 56,331 |
Total assets | 10,045 | 26,578 | 36,623 | 10,435 | 60,393 | 70,828 |
| Liabilities | ||||||
Creditors | (746) | (3) | (749) | (986) | (151) | (1,137) |
Derivative financial instruments | – | – | – | (24) | – | (24) |
Total liabilities | (746) | (3) | (749) | (1,010) | (151) | (1,161) |
31 December 2025 | 31 December 2024 | |||||
| GBP | Eur | Total | GBP | Eur | Total | |
| Assets | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Cash and cash equivalents | 1,615 | 244 | 1,859 | 3,957 | 3,663 | 7,620 |
Shareholder loan receivable | 27,514 | – | 27,514 | 27, 292 | – | 27,292 |
Trade and other receivables | 79 | – | 79 | 56 | – | 56 |
Investment in subsidiaries | 8,209 | 9,738 | 17,947 | 9,048 | 29,351 | 38,399 |
Total assets | 37,417 | 9,982 | 47,399 | 40,353 | 33,014 | 73,367 |
| Liabilities | ||||||
| Intercompany balance with Attika Holdings | ||||||
Limited | (10,859) | – | (10,859) | (2,443) | – | (2,443) |
Accrued expenses | (625) | – | (625) | (968) | – | (968) |
Total liabilities | (11,484) | – | (11,484) | (3,411) | – | (3,411) |
31 December 2025 | 31 December 2024 | |||||
| Interest | Non-interest | Interest | Non-interest | |||
| bearing | bearing | Total | bearing | bearing | Total | |
| Assets | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Cash and cash equivalents | 7,059 | 747 | 7,806 | 9,121 | 5,296 | 14,417 |
Trade and other receivables | – | 111 | 111 | – | 80 | 80 |
Derivative financial instruments | – | 274 | 274 | – | – | – |
Investments | 26,565 | 1,867 | 28,432 | 46,309 | 10,022 | 56,331 |
Total assets | 33,624 | 2,999 | 36,623 | 55,430 | 15,398 | 70,828 |
| Liabilities | ||||||
Creditors | – | (749) | (749) | – | (1,137) | (1,137) |
Derivative financial instruments | – | – | – | – | (24) | (24) |
Total liabilities | – | (749) | (749) | – | (1,161) | (1,161) |
31 December 2025 | 31 December 2024 | |||||
| Interest | Non-interest | Interest | Non-interest | |||
| bearing | bearing | Total | bearing | bearing | Total | |
| Assets | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Cash and cash equivalents | 1,148 | 711 | 1,859 | 3,971 | 3,649 | 7, 620 |
Trade and other receivables | – | 79 | 79 | – | 56 | 56 |
Shareholder loan receivable | 27,514 | – | 27,514 | 27, 292 | – | 27,292 |
Investments in subsidiaries | 9,738 | 8,209 | 17,947 | 29,351 | 9,048 | 38,399 |
Total assets | 38,400 | 8,999 | 47,399 | 60,614 | 12,753 | 73,367 |
| Liabilities | ||||||
| Intercompany balance with Attika Holdings | ||||||
Limited | – | (10,859) | (10,859) | – | (2,443) | (2,443) |
Accrued expenses | – | (625) | (625) | – | (968) | (968) |
Total liabilities | – | (11,484) | (11,484) | – | (3,411) | (3,411) |
31 December 2025 | 31 December 2024 | |||
| +0.5% | -0.5% | +0.5% | -0.5% | |
| Change | Change | Change | Change | |
| Discount rate | £’000 | £’000 | £’000 | £’000 |
Valuation | (14) | 14 | (59) | 61 |
31 December 2025 | 31 December 2024 | |||
| +0.5% | -0.5% | +0.5% | -0.5% | |
| Change | Change | Change | Change | |
| Discount rate | £’000 | £’000 | £’000 | £’000 |
Valuation | (58) | 60 | (86) | 88 |
31 December 2025 | 31 December 2024 | |||
| -10.0% | +10.0% | -10.0% | +10.0% | |
| Change | Change | Change | Change | |
| Power price | £’000 | £’000 | £’000 | £’000 |
Valuation | – | – | (48) | 51 |
31 December 2025 | 31 December 2024 | |||
| -10.0% | +10.0% | -10.0% | +10.0% | |
| Change | Change | Change | Change | |
| Energy yield | £’000 | £’000 | £’000 | £’000 |
Valuation | (56) | 56 | (296) | 297 |
31 December 2025 | 31 December 2024 | ||||
| Group | Company | Group | Company | ||
| Rating | £’000 | £’000 | £’000 | £’000 | |
Goldman Sachs-Liquid Reserves Fund | AAAmmf (Fitch Rating) | – | – | 249 | 249 |
EFG Bank | A (Fitch Rating) | 4,707 | 1,859 | 9,000 | 7,333 |
Royal Bank of Scotland International | AA- (Fitch Rating) | 3,015 | – | 5,013 | 38 |
Bank of New York Mellon | AA (Fitch Rating) | 84 | – | 155 | – |
7,806 | 1,859 | 14,417 | 7, 620 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| Group | £’000 | £’000 |
A | 5,415 | 4,346 |
B | 14,177 | 33,865 |
C | 952 | 8,098 |
D | 6,021 | – |
26,565 | 46,309 |
| Corresponding | |
| S&P rating | |
| Group | range |
A | AAA to A- |
B | BBB+ to BBB- |
| C BB to CC | |
| D Default |
| 31 December | 31 December | |
| 2025 | 2024 | |
| Less than 1 year | less than 1 year | |
| Liabilities | £’000 | £’000 |
Payables | 749 | 1,137 |
Derivative financial instruments | – | 24 |
749 | 1,161 |
| 31 December | 31 December | |
| 2025 | 2024 | |
| Less than 1 year | less than 1 year | |
| Liabilities | £’000 | £’000 |
Payables | 11,484 | 3,411 |
| Country of | |||||
Entity name and registered address | Effective ownership | Investment | incorporation | ||
| Attika Holdings Limited, Leaf B, 20th Floor, | 100% | HoldCo Subsidiary | United Kingdom | ||
| Tower 42, Old Broad Street, London, England, EC2N 1HQ | entity, which owns | ||||
| underlying | |||||
| investments | |||||
| Special purpose | |||||
| SPV Project 2013 S.r.l., Via Vittorio Betteloni, | 100% of the notes of | entity which owns | Italy | ||
2 | 20131, | Milan, Italy | one compartment | underlying | |
| investments. |